Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J.J. McGinnis
The Cost-Effectiveness of Hepatitis C Treatments in Treatment Naïve Genotype 1 Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Effectiveness of 8- Or 12-Weeks of Ledipasvir and Sofosbuvir in Real-World Treatment-Naïve, Genotype 1 Hepatitis C Infected Patients
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ledipasvir / Sofosbuvir for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Across Different Genotype 1 Clinical Subgroups
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pharmacist Intervention in Treatment of Patients With Genotype 1 Chronic Hepatitis C
Journal of Managed Care Pharmacy
Cost-Effectiveness of Sofosbuvir-Based Treatments for Chronic Hepatitis C in the US
BMC Gastroenterology
Medicine
Gastroenterology
Cost Effectiveness of Hepatitis C Treatments: Need for a Comprehensive Evaluation
Kaohsiung Journal of Medical Sciences
Medicine
A1-2: Cost-Effectiveness of Interleukin 28B Genotype-Guided Protease Inhibitor Therapy in Treatment-Naive Patients With Hepatitis C Virus Genotype 2 or 3
Clinical Medicine and Research
Medicine
Home Care
Community
Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients
PLoS ONE
Multidisciplinary